These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 14678959

  • 21. Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
    van den Broek GB, Wreesmann VB, van den Brekel MW, Rasch CR, Balm AJ, Rao PH.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4386-91. PubMed ID: 17671120
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Immunohistochemical staining for glutathione S-transferase predicts response to platinum-based chemotherapy in head and neck cancer.
    Nishimura T, Newkirk K, Sessions RB, Andrews PA, Trock BJ, Rasmussen AA, Montgomery EA, Bischoff EK, Cullen KJ.
    Clin Cancer Res; 1996 Nov 01; 2(11):1859-65. PubMed ID: 9816141
    [Abstract] [Full Text] [Related]

  • 24. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
    Li L, Yao D, Chen X.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb 01; 33(2):95-7. PubMed ID: 10682429
    [Abstract] [Full Text] [Related]

  • 25. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 26. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K, Hofele C, Knoepfle K, Gross M, Devens F, Dyckhoff G, Plinkert P, Lichter P, Herold-Mende C.
    J Oral Pathol Med; 2010 May 15; 39(5):382-9. PubMed ID: 20149059
    [Abstract] [Full Text] [Related]

  • 27. Frequent novel DNA copy number increase in squamous cell head and neck tumors.
    Brzoska PM, Levin NA, Fu KK, Kaplan MJ, Singer MI, Gray JW, Christman MF.
    Cancer Res; 1995 Jul 15; 55(14):3055-9. PubMed ID: 7606727
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.
    Minard CG, Spitz MR, Wu X, Hong WK, Etzel CJ.
    Cancer; 2006 Jun 15; 106(12):2636-44. PubMed ID: 16703596
    [Abstract] [Full Text] [Related]

  • 29. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.
    Anticancer Res; 2000 Jun 15; 20(1A):177-82. PubMed ID: 10769652
    [Abstract] [Full Text] [Related]

  • 30. Red blood cell glutathione levels before and during treatment with neoadjuvant chemotherapy cisplatin/5-fluorouracil in patients with head and neck squamous cell carcinoma.
    Massaad-Massade L, Domenge C, Rongeat S, Hassoun L, Legros MH, Ropers J, Janot F, Parise O, Gouyette A.
    Anticancer Res; 1998 Jun 15; 18(1A):283-8. PubMed ID: 9568091
    [Abstract] [Full Text] [Related]

  • 31. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629
    [Abstract] [Full Text] [Related]

  • 32. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R, Daidone MG, Veneroni S, Benini E, Scarfone G, Zanaboni F, Villa A, Presti M, Danese S, Bolis G.
    Cancer; 1998 Jan 01; 82(1):159-67. PubMed ID: 9428493
    [Abstract] [Full Text] [Related]

  • 33. High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer.
    Joshi MB, Shirota Y, Danenberg KD, Conlon DH, Salonga DS, Herndon JE, Danenberg PV, Harpole DH.
    Clin Cancer Res; 2005 Mar 15; 11(6):2215-21. PubMed ID: 15788669
    [Abstract] [Full Text] [Related]

  • 34. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas.
    Bockmühl U, Schwendel A, Dietel M, Petersen I.
    Cancer Res; 1996 Dec 01; 56(23):5325-9. PubMed ID: 8968077
    [Abstract] [Full Text] [Related]

  • 35. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization.
    Wang MB, Alavi S, Engstrom M, Lee J, Namazie A, Moatamed F, Srivatsan ES.
    Anticancer Res; 1999 Dec 01; 19(2A):925-31. PubMed ID: 10368635
    [Abstract] [Full Text] [Related]

  • 36. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization.
    Roman E, Meza-Zepeda LA, Kresse SH, Myklebost O, Vasstrand EN, Ibrahim SO.
    Oncol Rep; 2008 Oct 01; 20(4):825-43. PubMed ID: 18813824
    [Abstract] [Full Text] [Related]

  • 37. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
    Cheng X, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Okada M, Terakawa N.
    Cancer; 1997 Feb 01; 79(3):521-7. PubMed ID: 9028363
    [Abstract] [Full Text] [Related]

  • 38. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma.
    Woenckhaus J, Steger K, Werner E, Fenic I, Gamerdinger U, Dreyer T, Stahl U.
    J Pathol; 2002 Nov 01; 198(3):335-42. PubMed ID: 12375266
    [Abstract] [Full Text] [Related]

  • 39. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M.
    J Clin Oncol; 2006 Sep 10; 24(26):4333-9. PubMed ID: 16896002
    [Abstract] [Full Text] [Related]

  • 40. Detection of DNA damage in transcriptionally active genes by RT-PCR and assessment of repair of cisplatin-induced damage in the glutathione S-transferase-pi gene in human glioblastoma cells.
    Brandt TY, Ali-Osman F.
    Toxicol Appl Pharmacol; 1997 Mar 10; 143(1):22-9. PubMed ID: 9073588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.